Reopening its cannabis regulatory platform after months of disruption caused by the coronavirus, the Food and Drug Administration has prepared a draft bill to abolish a 5-year ban on the private sector making cannabis medicine.

Two draft ministerial regulations, one on marijuana and the other on hemp, under scrutiny since the end of last year and January respectively by the Council of State—the government’s legal arm—are also inching ahead following the easing of the lockdown.

Under these three pieces of legislation and regulations, foreigners will be allowed to get involved as long as they hold shares not exceeding one-third in a company incorporated under local law.

International travelers are the most relaxed category and are always eligible to apply for import and export licenses to bring in and take out cannabis medicine to treat their illnesses.